Welcome
Welcome to the Kentucky Lung Cancer Research Program website. Please check back often for updates on funding opportunities through the Program and information on other KLCR initiatives such as the Kentucky Clinical Trials Network, the Marty Driesler Lung Cancer CT Screening Project and other early detection studies, as well as the Markey Biospecimen Core Program.
News
KENTUCKY CLINICAL TRIALS NETWORK
CURRENT STUDIES
Protocol No. |
Title |
Status |
|---|---|---|
ACOSOG-Z4099 |
A Randomized Phase III Study of Sublobar Resection (+/- Brachytherapy) versus Stereotactic Body Radiation Therapy in High Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC) | Open |
| AMGEN-20070782 | Study to evaluate the Long-term Safety and Efficacy of Darbepoetin Alfa administered at 500 ug once-every-three-weeks in Anemic subjects with Advanced Stage Non-small cell lung cancer receiving multi-cycle chemotherapy | Open |
| CTN-0501 | Randomized Phase II Trial of Carboplatin and Gemcitabine with or without Dexamethasone in Patients with Untreated Stage IIIB-pleural effusion and Stage IV Non-Small Cell Lung Cancer | Closed to Accrual |
| CTN-0601 | Lung Cancer Survival in Kentucky: A Multifactorial Approach | Closed to Accrual |
| PFIZER-A7471009 | A Randomized, Double-Blind, Phase III Efficacy and Safety study of PF-00299804 versus Erlotinib for the treatment of Advanced Non-Small Cell Lung Cancer following progression after, or intolerance to, at least one prior chemotherapy | Closed to Accrual |
| BCC-LUN-10-STEREO | STEREOtactic Radiation and Adjuvant Chemotherapy in Lung Cancer (STEREO) | Open |
For additional information on study eligibility and to search for studies by treatment, disease type, and participating locations please click here: http://www.kctn.org/CurrentStudies/
To contact the KCTN Coordinating Center Team directly for study opportunities please click here: Kyclinicaltrialsnetwork@uky.edu
About Us
The Commonwealth of Kentucky has a disproportionately high incidence of lung cancer. Mortality from lung cancer exceeds the deaths from breast, colorectal, prostate and pancreatic cancer, combined. In an effort to improve survival of Kentuckians with lung cancer, the Kentucky General Assembly of 2000 established the Lung Cancer Research Fund (the Fund). This 20-year initiative encourages the combined efforts of the University of Kentucky and the University of Louisville in lung cancer translation and clinical research, early detection and epidemiology initiatives, and the development of the Kentucky Clinical Trials Network. Read more...
Program Highlight: Kentucky Clinical Trials Network
The Kentucky Clinical Trials Network (KCTN) is one of the primary initiatives included in the Kentucky Lung Cancer Research Program. The Kentucky General Assembly wanted to support an increased number of clinical trials in lung cancer. KCTN is a statewide alliance of physicians conducting clinical trials in the prevention, early detection, and treatment of lung cancer. The Network conducts investigator-initiated and industry sponsored trials. Read more...